Researchers expand plasmonic liquid biopsy platform to early-stage colorectal cancer

Дата публикации: 09-07-2026 13:20:11

A research team led by Minyoung Lee and Sunggyu Park of The Korea Institute of Materials Science (KIMS) Bio & Health Materials Research Division has developed a plasmonic-based liquid biopsy platform capable of ultrasensitive detection of KRAS mutations in the blood and urine of patients with early-stage colorectal cancer.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Blood test may help identify which colorectal cancer patients most likely to benefit from chemotherapy after surgery	0	5	06-07-2026
2	Breakthrough blood test that spots earliest-stage colorectal cancer approved for use - available from the fall	0	12.68	04-08-2026
3	New brush test detects oral cancer in one hour	7	8	06-07-2026
4	Silicon-slide imaging could speed cancer diagnosis with 99% agreement, no dyes needed	6	7	15-06-2026
5	New blood test for noncoding RNA significantly improves cancer detection	7	8	31-08-2023
6	Ultrasensitive blood test predicts head and neck cancer relapse months earlier	5	7	10-06-2026
7	Anticancer 'nanoswitch' technology shows promise in animal model of triple-negative breast cancer, colorectal cancer	5	7	10-07-2026
8	Blood test finds hidden pancreatic cancer after treatment	5	8	30-06-2026
9	New urine-based test detects high-grade prostate cancer, helping men avoid unnecessary biopsies	5	7	18-04-2024
10	Mass spectrometry platform could shrink cancer drug discovery cycle to four hours	7	8	20-06-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 7. Источник: medicalxpress.com.